Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study
- 1 January 2014
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 15 (1), 23-34
- https://doi.org/10.1016/s1470-2045(13)70546-1
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry dataThe Lancet, 2011
- Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE projectBlood, 2010
- The size of the prize for earlier diagnosis of cancer in EnglandBritish Journal of Cancer, 2009
- Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results?British Journal of Cancer, 2009
- The National Awareness and Early Diagnosis Initiative in England: assembling the evidenceBritish Journal of Cancer, 2009
- Treatment and survival in breast cancer in the Eastern Region of EnglandAnnals of Oncology, 2009
- Survival of European children and young adults with cancer diagnosed 1995–2002European Journal of Cancer, 2009
- EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentaryEuropean Journal of Cancer, 2009
- Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990sEuropean Journal of Cancer, 2008
- Non-standard management of breast cancer increases with age in the UK: a population based cohort of women ⩾65 yearsBritish Journal of Cancer, 2007